These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6799690)

  • 1. [In vitro effects of several kinds of gas exposure on the antimicrobial activities of antituberculous agents. Chapter I. Bacteriostatic effects (author's transl)].
    Yamadori H
    Kekkaku; 1981 Sep; 56(9):429-33. PubMed ID: 6799690
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro effects of several kinds of gas exposure on the antimicrobial activities of antituberculous agents. Chapter II. Bactericidal effects (author's transl)].
    Yamadori H
    Kekkaku; 1981 Oct; 56(10):465-70. PubMed ID: 6798295
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro effects of several kinds of gas exposure on the antimicrobial activities of antituberculous agents. Chapter III. The development of drug resistance (author's transl)].
    Yamadori H
    Kekkaku; 1981 Nov; 56(11):521-4. PubMed ID: 6799686
    [No Abstract]   [Full Text] [Related]  

  • 4. [A comparative study of the relationship between the growth rate of tubercle bacilli and the concentration of antituberculous agents (author's transl)].
    Tsukamura M; Mizuno S
    Kekkaku; 1980 Aug; 55(8):365-70. PubMed ID: 6775122
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. V. Incubating temperature and chemotherapeutic effects. 2 (author's transl)].
    Maekawa N; Ikeda N; Uratsuji Y
    Kekkaku; 1973 Nov; 48(11):913-5. PubMed ID: 4210479
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antitubercular properties of some derivatives of pyrazine carboxylic acid].
    Solov'ev VN; Pavolo EP
    Farmakol Toksikol; 1967; 30(6):734-7. PubMed ID: 4970686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative studies on in vitro activities of important antituberculous drugs].
    Ikeda N
    Kekkaku; 1986 May; 61(5):285-92. PubMed ID: 3090342
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
    Abate G; Koivula T; Hoffner SE
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):933-5. PubMed ID: 12365582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current concepts on the occurrence of bacilli visible during bacteriostatic studies but not growing in cultures in patients with pulmonary tuberculosis].
    Górnicka-Wilczyńska M
    Pneumonol Pol; 1982; 50(1-2):51-6. PubMed ID: 6812027
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthesis of Nevadensin analogues and their anti-tuberculosis activity (author's transl)].
    Tang CF; Xi GL; Gu KJ; Zhang HL; Guo XY
    Yao Xue Xue Bao; 1981 Oct; 16(10):787-92. PubMed ID: 6801922
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies of antituberculous activity in vitro and serum specific antibacterial activity test of PAS and PASCON].
    Ogawa M; Osaki T; Kawabata H
    Iryo; 1970 Jun; 24(6):484-7. PubMed ID: 4989589
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.
    Gumbo T; Louie A; Deziel MR; Parsons LM; Salfinger M; Drusano GL
    J Infect Dis; 2004 Nov; 190(9):1642-51. PubMed ID: 15478070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiology and diagnosis of tuberculosis.
    Fadda G; Sanguinetti M
    Rays; 1998; 23(1):32-41. PubMed ID: 9673132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antituberculous activity in plant extracts.
    Grange JM; Davey RW
    J Appl Bacteriol; 1990 Jun; 68(6):587-91. PubMed ID: 2118130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ.
    Reynolds RC; Srivastava S; Ross LJ; Suling WJ; White EL
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3161-4. PubMed ID: 15149666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental antituberculous action of a new antibiotic: RP 11,072].
    Noufflard-Guy-Loé H; Berteaux S
    Rev Tuberc Pneumol (Paris); 1965 Apr; 29(4):301-26. PubMed ID: 4953631
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sensitivities of atypical mycobacteria to various drugs. I. Sensitivities to antituberculous drugs (author's transl)].
    Kuze F; Takeda S; Maekawa N
    Kekkaku; 1974 Jun; 49(6):151-6. PubMed ID: 4410839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.